CFMS stock forecast
Our latest prediction for Conformis Inc.'s stock price was made on the Nov. 3, 2021 when the stock price was at 1.24$.
In the short term (2weeks), CFMS's stock price should outperform the market by 3.81%. During that period the price should oscillate between -9.93% and +14.93%.
In the medium term (3months), CFMS's stock price should outperform the market by 17.14%. During that period the price should oscillate between -35.43% and +43.57%.Get email alerts
Create a solid portfolio with CFMS
About Conformis Inc.
Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which Conformis refers to as personalized, individualized, or sometimes as customized, to fit each patient's unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers. In clinical studies, the Conformis iTotal® CR knee replacement system demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
At the moment the company generates 103M USD in revenues.
On its last earning announcement, the company reported a loss of -0.34$ per share.
The book value per share is 0.78$
Three months stock forecastNov. 3, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|